Regulation & Compliance

The advisory giant continues its aggressive national expansion, adding a key Minneapolis firm and signaling a new competitive era for Midwest wealth management.

WTW launches a new AI platform to transform compensation strategy, promising faster, data-driven insights and a more strategic role for HR professionals.

JScreen, Manischewitz, and advocate Gila Pfeffer offer low-cost cancer and carrier genetic tests in NYC, transforming community health access.

A new liquid biopsy more accurately predicts cancer recurrence than standard methods, offering new hope and clarity for patients after surgery.

vTv Therapeutics shores up its finances with a deal worth up to $135M, sharpening its focus on a breakthrough Type 1 diabetes drug, cadisegliatin.

Commvault's new solution addresses rising global demand for data control, helping organizations navigate complex regulations without sacrificing cyber resilience.

Gen II Fund Services unveils its AI-powered Sensr Portal, promising to transform private market data access from static reports to conversational insights.

The RegTech firm, once a cannabis banking specialist, unveils a major rebrand and expands its platform to tackle digital assets and Money Services Businesses.

As Canadians face record debt, a new federal campaign offers free financial tools. But can online resources truly combat a national cost-of-living crisis?

Shanghai's AI EdTech innovator Jinxin faces a potential Nasdaq delisting after its stock plummets, putting its high-tech vision against market reality.

The Spanish biotech firm strengthens its IP for a novel aggression treatment, targeting a growing multi-billion dollar Japanese CNS market.

A state-funded grant unites UCLA and industry to create a scientific benchmark for cannabis flavors, aiming to enhance public safety and regulatory clarity.

Tenet Healthcare finalizes a multi-billion dollar deal with CommonSpirit, regaining full control of Conifer and signaling major investments in AI and automation.

After its stock plummeted post-IPO, Chinese health-tech firm POMDOCTOR faces a Nasdaq delisting threat, forcing a reckoning with its massive losses.

A new FinTech giant is born. Teciem spins out of Finastra with Apax backing, a $2B valuation, and a plan to innovate for the world's top banks.

A life-changing treatment for a rare kidney disease is now easily accessible in France, ending a long wait for patients and bolstering a French pharma firm.

Early clinical results for MP0712, a novel Radio-DARPin, suggest a breakthrough for targeting aggressive cancers like SCLC while sparing healthy tissue.

After 18 negotiating sessions, 1,200 Teamsters at Rush University Medical Center won a new contract with major wage and benefit gains, setting a new bar.

A lawsuit seeks to block drastic cuts to Florida's ADAP program, which could strip thousands of life-saving HIV medication and insurance by March 1.

The Corrections Center of Northwest Ohio lauds a smooth healthcare transition, but its new partner, Armor Health, brings a history of lawsuits and financial turmoil.